← Back to headlines
AbbVie Announces Positive Phase 3 Results for Epkinly in Lymphoma Treatment
Pharmaceutical company AbbVie has reported positive Phase 3 clinical trial results for its drug Epkinly, showing efficacy in treating second-line large B-cell lymphoma.
29 Jun, 22:28 — 29 Jun, 22:28
Sources
Showing 1 of 1 sources
